ArticleCancer immunology, immunotherapy : CII2007

Gene-modified T cells for adoptive immunotherapy of renal cell cancer maintain transgene-specific immune functions in vivo.

Cor H J Lamers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.